Acceder

Publicaciones - CARDIOLOGIA CLINICA Y EXPERIMENTAL

Cargando...
Valverde-Bolivar E, Simonelli-Munoz AJ, Rivera-Caravaca JM, Gallego-Gomez JI, Rodriguez Gonzalez-Moro MT, Garcia-Arenas JJ. Occupational Therapy in Severe Mental Disorder-A Self-Controlled Quasi-Experimental Study. Healthcare (Basel). 2022 Mar 8;10(3):493. doi: 10.3390/healthcare10030493. PubMed PMID: 35326971; PubMed Central PMCID: PMC8954915.
AÑO: 2022; IF: 3.16
35326971
Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Sanmartin Fernandez M, Arribas F, Masjuan J, Barrios V, Cosin-Sales J, Freixa-Pamias R, Recalde E, Perez-Cabeza AI, Manuel Vazquez Rodriguez J, Rafols Priu C, Anguita Sanchez M, Lip GYH, Marin F. Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15;9(1):38-46. doi: 10.1093/ehjcvp/pvac060. PubMed PMID: 36318457.
AÑO: 2022; IF: 7.1
36318457
Esteve-Pastor MA, Ruiz-Ortiz M, Muniz J, Roldan-Rabadan I, Otero D, Cequier A, Bertomeu-Martinez V, Badimon L, Anguita M, Lip GYH, Marin F. Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry. Front Cardiovasc Med. 2022 May 2;9:856222. doi: 10.3389/fcvm.2022.856222. eCollection 2022. PubMed PMID: 35586656; PubMed Central PMCID: PMC9108173.
AÑO: 2022; IF: 3.6
35586656
Romiti GF, Proietti M, Vitolo M, Bonini N, Fawzy AM, Ding WY, Fauchier L, Marin F, Nabauer M, Dan GA, Potpara TS, Boriani G, Lip GYH; ESC-EHRA EORP-AF General Long-Term Registry Investigators. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry. BMC Med. 2022 Sep 2;20(1):326. doi: 10.1186/s12916-022-02526-7. PubMed PMID: 36056426; PubMed Central PMCID: PMC9440492.
AÑO: 2022; IF: 9.3
36056426
Palau P, Amiguet M, Dominguez E, Sastre C, Mollar A, Seller J, Garcia Pinilla JM, Larumbe A, Valle A, Gomez Doblas JJ, de la Espriella R, Minana G, Mezcua AR, Santas E, Bodi V, Sanchis J, Pascual-Figal D, Gorriz JL, Bayes-Genis A, Nunez J; DAPA-VO2 Investigators (see Appendix). Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2 ): a randomized clinical trial. Eur J Heart Fail. 2022 Oct;24(10):1816-1826. doi: 10.1002/ejhf.2560. Epub 2022 Jun 6. PubMed PMID: 35604416.
AÑO: 2022; IF: 18.2
35604416
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

CARDIOLOGIA CLINICA Y EXPERIMENTAL